Urgent action is needed to improve the diagnosis and management of CDI, which is the main cause of hospital-acquired (nosocomial) diarrhoea in industrialised countries.2 In a report launched today, during a meeting hosted by the European Healthcare and Hospital Federation (HOPE), experts from across Europe highlight the current deficiencies in the management of CDI and outline the steps that are needed to address them.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60637-astellas-report-diagnosis-management-CDI
The European Space Agency (ESA) has joined the CEMS global alliance as the first partnership of its kind, at a meeting in Brussels last month.
Established in 1988 by four leading European business schools (Università Bocconi, ESADE, HEC Paris and the University of Cologne), CEMS has grown into a 29-school partnership, collaborating with 70 Corporate, four Social Partners, together offering a Masters in International Management (MIM) programme.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7396551-European-Space-Agency-joins-CEMS/
The highly anticipated luxury, all–suite Delano Las Vegas debuted today bringing a touch of South Beach to The Strip. This morning, executives and employees of MGM Resorts International and Morgans Hotel Group gathered to officially unveil Las Vegas’ newest hotel.
“Delano Las Vegas marks a new chapter in the Las Vegas hotel experience, ushering in elevated levels of personalized service, style and attention to detail,” said General Manager Matthew Chilton. “We’re challenging the quintessential over–the–top Vegas experience by introducing a new brand focused on understated luxury, appealing to in–the–know travelers,” added Chilton.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7308751-delano-las-vegas-debuts-on-las-vegas-strip/
The collection features a tightly edited range that effortlessly takes you from one city to another. The iron-free “Good Traveler Shirt” and the versatile dark navy travel suit will ensure serious style, even when stepping off the plane to attend a business meeting or dinner.
With an energetic delivery of updated preppy icons, GANT Diamond G offers perfect pieces for both on and off-duty occasions. For the holiday season, the focus is a tightly curated edit of the cocktail cuff shirt for him and the cocktail dress for her. In addition, GANT Diamond G offers the perfect tuxedo made of Italian fabric – giving off that classic GANT look, now with a sophisticated European edge.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7769051-gant-diamond-g-fall-winter-2016/
Swedish company Evoko Unlimited is now launching the new conference phone Evoko Minto in America. It’s the start of a new era, as Evoko’s patented sound-improvement software eliminates background noise and distractions for maximum clarity.
“Corporate America has to stop meeting the way it is,” says Richard Glückman, General Manager at Evoko. “With Evoko Minto, we want to start a new era of phone conferencing by offering a unique sound technology that gets your voice through clearly and a design that makes your meeting look great.”
To view the Multimedia News Release, go to http://www.multivu.com/mnr/71400541-evoko-introduces-minto-phone-conferencing
The American Society for Aesthetic Plastic Surgery (ASAPS), is hosting a panel discussion today on the fast-evolving practice of fat grafting, and how surgeons are discovering best practices to produce the most natural looking results. Physician members of ASAPS concur that less is more when it comes to utilizing a patient’s own fat to enhance certain anatomical regions including the breast and buttocks. Further, they agree that fat grafting is proving to be a novel technique for body sculpting previously neglected areas including women’s and men’s shoulders, pectorals, legs and stomachs to create definition.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7310752-asaps-plastic-surgery-fat-grafting/
Chiasma, Inc., a U.S. privately–held biopharma company developing octreotide capsules for the orphan condition acromegaly, today announced two new studies presented at the 97th Endocrine Society (ENDO) Annual Meeting in San Diego, Calif. The studies provide additional data from Chiasma’s Phase III trial and new findings on the patient burden of current injection therapies.
“We now have data to help clinicians determine whether octreotide capsules, if approved, are likely to help their patient with acromegaly maintain response,” said Shlomo Melmed, M.D., senior vice president and dean, Cedars–Sinai Medical Center, Los Angeles and global study principal investigator. “Furthermore, the Phase III results show the safety and efficacy of octreotide capsules can be reliably determined within 12 weeks of initiating therapy.”
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7436451-endo-chiasma-clinical-data/
